Inner Banner

International 2025

breadCrumb

Submitted by admin on Tue, 11/26/2024 - 17:11
Type
common
  1. Agrawal N, Govekar R (2025). Incremental modification in the existing approaches for affinity chromatographic enrichment of phosphoproteins improves their profile in liquid chromatography-tandem mass spectrometry analysis. Analytical Science Advances. 6(1):e202400058.

  2. Bjelic- Radisic V, Cardoso F, Weis J....Nookala M...Duhoux F...etal. on behalf of the EORTC Quality of Life Group and Breast Cancer Group (2025). An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42. The Breast. PMID: 39947087

  3. Bhosale S, Golani A, Joshi M, Kulkarni A (2025). Perioperative euglycemic DKA: The YIN and YANG of sodium-glucose cotransporter 2 inhibitors. Journal of Anaesthesiology Clinical Pharmacology 41(1): 193-195.

  4. Bajpai J, Sarkar L, Rath S, Chandrasekharan A, Panda G, Jakar D, Pawar A, Ghosh J, Laskar S, Rekhi B, Khanna N, Manjali JJ, Ramadwar M, Purandare N, Bhargava P, Chakrabarty N, Gala K, Kembhavi Y, Rangarajan V, Banavali S, Gupta S (2025). Ten-year follow-up of outcomes, patterns of care, and psychosocial burden in adolescent and young adult (AYA) patients with bone sarcomas from a large cohort in a low-income and middle-income country (LMIC). Cancer. 131(1): e35547. PMID: 39297373

  5. Bajpai J, Sarkar L, Rath S, Pawar A, Chandrashekharan A, Panda G, Jakar D, Ghosh J, Laskar S, Rekhi B, Khanna N, Jose J, Ramdawar M, Purandare N, Bhargava P, Chakrabarty N, Gala K, Kembhavi Y, Rangarajan V, Banavali S, Gupta S (2025). Prognostic modeling for bone sarcomas based on a large prospective cohort from a tertiary care cancer center in India. JCO Global Oncology.

  6. Bal M, Nath PS, Janu A, Thiagarajan S, Pantavaidya G (2025). First report of SMARCA4-deficient carcinoma ex-pleomorphic adenoma in salivary glands. Histopathology. 86(3):480-482. PMID: 39502002

  7. Bhat M, Saha P, Narasimhan M, Shelar A, Hole A, CM Krishna, Govekar R (2025). Analysis of lipids by Raman spectroscopy and mass spectrometry provides a detection tool and mechanistic insight into imatinib resistance in CML-BC. Biochimica et Biophysica Acta (BBA) - General Subjects.

  8. Chaudhary N, Choudhary BS, Shivashankar A, Manna S, Ved K, Shaikh S, Khanna S, Baar J, Dani J, Sahoo S, Soundharya R, Jolly MK, Verma N. EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. Cancer Cell International. 25(1):55. PMID: 39972345.

  9. Cepeda S, Esteban-Sinovas O, Singh V, Moiyadi A, Zemmoura I, Del Bene M, Barbotti A, DiMeco F, West TR, Nahed BV, Giammalva GR, Arrese I, Sarabia R. Prognostic modeling of overall survival in glioblastoma using radiomic features derived from intraoperative ultrasound: A multi-institutional study. Cancers. 17(2):280. PMID: 39858063.

  10. Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan L, Giannakopoulus N, Schmid M, Tanderup K, Pötter R, Nout R (2025). Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE. International Journal of Radiation Oncology, Biology, Physics. 127(1): 97-106.PMID: 39067486

  11. Cepeda S, Esteban-Sinovas O, Singh V, Shetty P, Moiyadi A, Dixon L, Weld A, Anichini G, Giannarou S, Camp S, Zemmoura I, Giammalva GR, Del Bene M, Barbotti A, DiMeco F, West TR, Nahed BV, Romero R, Arrese I, Hornero R, Sarabia R. Deep learning-based glioma segmentation of 2D intraoperative ultrasound images: A multicenter study using the Brain Tumor Intraoperative Ultrasound Database (BraTioUS). Cancers. 17(2):315. PMID: 39858097.

  12. Chatterjee G, He R, Patkar N, Viswanatha D, Langerak AW. Molecular techniques in haematopathology: what and how? Histopathology. 86(1):38-57. PMID: 39403025

  13. Chaudhary N, La Ferlita A, Choudhary BS, Jog E, Kazi M, Yahya S, Dalwai A, Ostwal V, Kumar S, Redkar S, Khapare N, Kailaje V, B A, Gera P, Bal M, Verma N, Thorat R, Saklani A, Sehgal L, Dalal SN (2025). Patient-derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas. Clinical Cancer Research. PMID: 39879477

  14. Chen X, Patkar N, Tembhare P, Papagudi S,Yeung C, Kanagal Shamanna R, Gujral S, Wood B,Naresh KN (2025). Fifth edition WHO classification: myeloid neoplasms. Journal of Clinical Pathology

  15. Cortes J, Kim D-W, Saikia T, Khattry N, Rathnam K, Alvarado Y, Hannah G, Tantravahi S, Apperley J, Charbonnier A, García-Gutiérrez V, Lucchesi A, Dima D, Illés Á, Popav V, Abruzzese E, Nag A, Apte S, Badar T, Yao S-L, Saxena U, Sreenivasan J, Inamdar S, Chimote G, Nicolini F (2025). Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial. Lancet Haematology.

  16. Dholam KP, Somani P, Gurav S, Dugad J, Kharade P, Rane PP, Singh GP (2025). Longitudinal assessment of trismus in patients with advanced stage oral and oropharyngeal cancer. Journal of Prosthetic Dentistry.

  17. Dinesan A, Singh M, Mehta P, Maitre P, Murthy V (2025). Acute enteritis with pelvic SBRT: Influence of bowel delineation methods. Clinical and Translational Radiation Oncology.

  18. Dalal N, Dhandapani H, Ingle A, Sharma D,Tayalia P. Functionalized Poly(ethylene Glycol) diacrylate scaffolds for In Situ immunomodulation of dendritic cells targeting melanoma tumor. ACS Biomaterials Science & Engineering

  19. Dwivedi P, Barage S, Jha AK, Choudhury S, Rangarajan V (2025). Robustness of 18F-FDG PET radiomic features in lung cancer: Impact of advanced reconstruction algorithm. Journal of Nuclear Medicine Technology.

  20. Gore S, Mhamane S, Jadhav S, Padvi N, Mhatre A,Joshi P, Sawakare S, Samant V, Chaturvedi P,Pramesh CS, Gupta S, Budukh A. Implementation challenges of government-funded health schemes for cancer treatment at Tata Memorial Centre. Journal of Cancer Policy. 43:100564.

  21. Gaikwad P, Bargir UA, Jodhawat N, Dalvi A, Shinde S, Tamhankar P, Setia P, Kambli P, Dhawale A, Temkar L, Vedpathak D, Jose A, Gupta M, Yadav-Malik R, Dutta S, Bose K, Taur P, Gowri V, Iyengar V, Chougule A, Desai M, Sivasankaran M, Bhattad S, Balaji S, Mudaliar S, Kacha A, Subramanian G, Patel S, Sharma S, Sampagar A, Madkaikar M. Mutational Landscape of Patients with Wiskott Aldrich Syndrome: Update from India. Journal of Clinical Immunology. 45(1):56. PMID: 39688652

  22. Gokarn A, Reddy L, Hiregoudar S, Poojary M, Parab S, Punatar S, Chichra A, Mirgh S, Jindal N, Nayak L, Garg K, Saho S, Ojha S, Tembhare P, Rajpal S, Chatterjee G, Patkar N, Kannan S, Pawar A, Bagal B, Subramanian PG, Khattry N (2025). A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilization. Cytotherapy.

  23. Guévelou JL, Sargos P, Ost P, Alongi F, Arcangeli S, Berlin A, Blanchard P, Bruynzeel A, Chapet O, Dal Pra A, Dess RT, Guckenberger M, Loblaw A, Kishan AU, Jereczek-Fossa B, Pasquier D, Shelan M, Siva S, Tree AC, Zamboglou C, Supiot S, Murthy V, Zilli T (2025). Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey. Clinical and Translational Radiation Oncology. 51:100907. PMID: 39845565

  24. Ghosh A, Chaubal R, Das C, Parab P, Das S, Maitra A, Majumder PP, Gupta S, Biswas NK (2025). Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours. Communications Biology. 8(1):207.

  25. Gupta SK, Yadav S, Sharma D, Sandur SK, Khattry N, Goda JS, Gota V(2025). Effect of the radioprotector chlorophyllin on graft versus leukemia response in experimental allogeneic hematopoietic stem cell transplantation. Journal of Ayurveda and Integrative Medicine. 16(2):101109

  26. Goyal P, Kumar M, Kiran M, Srivastava S, Roy S, Garg S, Salunke S, Lader S, Quadir K, Ansari A, Fatima Z, Qayyumi B, Tuljapulkar V, Chaturvedi P (2025). Optimizing Surgical Margins in Oral Cancer without Frozen Section: A single center retrospective study. European Journal of Surgical Oncology. 51(1): 109360. PMID: 39571517

  27. Halder A, Jadhav PA, Maitra A, Banerjee A, Hole A,Epari S, Shetty P, Moiyadi A, CM Krishna,Srivastava S (2025). Serum Metabolomics Profiling Coupled with Machine Learning Identifies Potential Diagnostic and Prognostic Candidate Markers in Meningioma Using Raman Spectroscopy, ATR-FTIR, and LC-MS/MS. Journal of Proteome Research

  28. Hait S, Noronha V, Chowdhury A, Chaudhary A, Bawaskar B, Dahimbekar G, Ahmad S, Joshi A, Patil V, Menon N, Shah M, Kaushal R, Choughule A, Bharde A, Khandare J, Shafi G, Lakhwani D, Desai S, Chandrani P, Prabhash K, Dutt A (2025). The impact of co-occurring tumor suppressor mutations with mEGFR as early indicators of relapse in lung cancer. ESMO Open, 10(4):104479.

  29. Jadhav PA, Hole A, Saha P, Pansare K, Ghanwat A, Gera P, Bendale K, Krishna CM, Chaudhari P (2025). Exploratory Raman Spectroscopic Studies of Canine Oral tumour types. Journal of Biophotonics.

  30. Jeeva M, Dasgupta A, Chatterjee A, Sahu A, Sridhar E, Moiyadi A, Chinnaswamy G, Gupta T (2025). Third course of radical intent conformal radiation in patients with primary brain tumors. Clinical Oncology.

  31. Jog E, Jainarayanan AK, Ferlita A, Chakraborty A, Dalwai A, Yahya S, Shivashankar A, Choudhary B, Chandramouli A, Kazi M, Jain D, Khapre N, Akshaya B, Khan B, Gera P, Patil P, Thorat R, Verma N, Sehgal L, Saklani A, Kamat S, Dalal SN, Choudhary N (2025). Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer. Redox Biology.79:103458.

  32. Joshi P, Kole L, Patil A, Singh A, Shetty R, Nair S, Chaturvedi P (2025). A retrospective study of lip carcinoma at a tertiary cancer centre. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.

  33. Katawale S, Tank S, Dhaygude H, Holm R, Shah S, Shinde U, Shidhaye S, Joshi G, Warawdekar U, Nagarsenker M (2025). Systemic delivery of Sorafenib Tosylate loaded LeciPlex®: A comparative assessment of nano assembly, biocompatibility, and in vivo drug disposition. Journal of Drug Delivery Science and Technology

  34. Keith B, Welch DR, Agarwal N, Blair C, Chukwudozie IB, Shevde LA, Boise LH, Burnstein KL, Antalis TM, O'Connor KL, Dalal SN, Ellis S, Nakshatri H. Challenges and opportunities in training cancer researchers. Nature Cancer. PMID: 39747649

  35. Keshari R, Bagale R, Rath S, De A, Banerjee R, Sen S, Srivastava R (2025). Transcutaneous delivery of disease-specific PI3K/Akt/mTOR inhibitor-based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies. International Journal of Pharmaceutics.672:125325. PMID: 39954975

  36. Khanna D, Mishra A, Birur P, Shruti T, Gurushanth K, Mukhia N, Pathak R, Gurmeet Singh A, Shetty A, Pradhan S, Chaturvedi P. A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India. Cancer. 131(1): e35702. PMID: 39748663

  37. Khanvilkar S, Mittra I (2025). Copper imparts a new therapeutic property to resveratrol by generating ROS to deactivate cell-free chromatin. Pharmaceuticals. 18(1):132. PMID: 39861193.

  38. Kumar B, Mittal P, Gupta A, Mulani J, Bhajbhuje R, Kannan S, Jain J, Chopra S (2025). Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective study. Brachytherapy.

  39. Kumar S, Dey P, Pathak AK, Wadawale A, Maurya DK, Natu K, Bose K, Goswami D (2025). Structure-activity relationship of ciprofloxacin towards S-Spike Protein of SARS-CoV-2: Synthesis and In-silico evaluation. Journal of Chemical Information and Modeling. 65(2):825-844. PMID: 39800972

  40. Kumar S, Joshi A, Takke A, Varghese D, Pathak S, Noronha V, Kumar P, Gota V (2025). Comparison of PSA response to generic versus innovator (Zytiga) formulations of abiraterone in metastatic CRPC: A retrospective analysis. Indian Journal of Medical and Paediatric Oncology.

  41. Kumar S, Dey P, Pathak AK, Wadawale A, Maurya DK, Natu K, Bose K, Goswami D. Structure-activity relationship of ciprofloxacin towards S-Spike Protein of SARS-CoV-2: Synthesis and In-silico evaluation. Journal of Chemical Information and Modeling. 65(2):825-844.

  42. Lester-Coll N, Pra A, Murthy V, Kamran S (2025). Advancements in prostate cancer radiotherapy: The role of PSMA PET imaging, Practical Radiation Oncology.

  43. Lonare A, Raychaudhuri K, Shah S, Madhu G, Sachdeva A, Basu S, Thorat R, Gupta S, Dalal SN (2025). 14-3-3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer. International Journal of Cancer.156(3):623-637.PMID: 39239852

  44. Mahajan A, Panzade G, Bhuniya T, Das P, Bhattacharjee B, Das S, Chowdhury A, Chakraborty K, Guha S, Samant A, Dey A, Ghosh S (2025). Revolutionizing lung cancer treatment: Introducing PROTAC therapy as a novel paradigm in targeted therapeutics. Current Problems in Cancer. 54:101172. PMID: 39731828.

  45. Maitre P, Zaorsky N, Dess R, Koontz B, Tree A, Zilli T (2025). Precision over tradition: Transforming prostate cancer treatment with stereotactic radiation therapy. International Journal of Radiation Oncology,Biology Physics. 121(5): 1093-1097.

  46. Mahaddalkar T, Banerjee A, Ketkar M, Thorat R, Gardi N, Dutt S (2025). Aurora Kinase A and B inhibition abrogates 'Neosis', a non-mitotic cell division of GBM residual cells and prevents GBM recurrence. Oncogene.

  47. More A, Parikh P, Kamtalwar S, Pagdhune A (2025). A case series of Pseudohyperkalemia: A diagnostic dilemma in cancer patients with reactive thrombocytosis. Cureus. 17(4):e81851.

  48. Mukhare R, Gandhi KA, Kadam A, Raja A, Singh A, Madhav M, Chaubal R, Pandey S, Gupta S (2025). Integration of organoids with CRISPR screens: A narrative review. Biology of the Cell. 117(4):e70006

  49. Mirgh S, Lall S, Punatar S, Gokarn A, Jindal N, Chichra A, Bhat V, Khattry N (2025). Dirt Under the finger-nails-more malignant than malignancy. American Journal of Hematology.

  50. Murthy V, Marvaso G, Jereczek-Fossa BA, Thoma SA, Vogel M, Schmidt-Hegemann NS, Shelan M, Siva S, Hoelscher T, Kishan AU, Peeken JC, Gillessen S, Guckenberger M, Herrmann K, Fendler WP, Zilli T, Spohn SKB, Zamboglou C (2025). The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care. European Urology. PMID: 39837736.

  51. Maity A, Sathyanarayanan A, Kumar R, Vora J, Gawde J, Jain H, Bagal B, Subramanian PG, Sengar M MD, DM, Khattry N, Patkar N, Hasan SK (2025). RAPID-CRISPR: Highly sensitive diagnostic assay for detection of PML-RARA isoforms in acute promyelocytic leukemia. Blood Advances. 9(3):463-47. PMID: 39622167

  52. Mishra GA, Pimple SA, Anand KV, Kulkarni VY, Patil AS, Biswas SK (2024). Acceptability and validity of HPV self-sampling for cervical cancer screening among women living in different ecological settings in India. International Journal of Cancer. 156(6):1142-1153. PMID: 39412108

  53. Mahajan A, Agarwal U, Ashtekar RM, Chakrabarty N,Vaish R, Patil VM, Noronha V, Menon N, Smriti V,Agarwal JP,Ghosh-Laskar S, D'Cruz AK, Chaturvedi P, Pai P, Patil A, Bal M, Rane S, Mittal N, Prabhash K (2025). Compartmentalization of high infratemporal Fossa in oral cavity squamous cell carcinomas and its impact on clinical outcome. Current Oncology.

  54. Murthy V, Dal Pra A (2025). Transporting testosterone home: Navigating the Road to Recovery. European Urology. 87(1): 58-59. PMID: 39472203.

  55. Mojidra R, Gardi N, Bagal B, Khattry N, Gokarn A, Punatar S, Govekar R (2025). Genomic analysis identifies an incipient signature to forecast imatinib resistance before start of treatment in patients with chronic myeloid leukemia. Advances in Biomarker Sciences and Technology

  56. Noronha V, Menon N, Patil VM, Shah M, Joshi A, Shah S, Nawale K, Surve R, Bafna G, Jogdhankar S, Shelar P, Shetake A, Singh A, Salian S, Jadhav P, Shah H, Mer N, Vohra A, Majumdar S, Banavali S, Badwe R, Prabhash K (2025). Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial. British Journal of Cancer. 132(1):58-68. PMID: 39592738.

  57. Oak S, Karajgikar O, Gadewal N, Sulkshane P, Verma T, Gupta S, Teni T (2025). The deubiquitinase inhibitor WP1130 drives nuclear aggregation and reactivation of mutant p53 for selective cancer cell targeting. FEBS Journal.

  58. Pachuau L, Lalremmawia H, Ralte L, Vanlalpeka J, Pautu JL, Chenkual S, Zomuana T, Lalruatfela ST, Zohmingthanga J, Chhakchhuak L, Varma AK, Kumar NS (2025). Uncovering novel pathogenic variants and pathway mutations in triple-negative breast cancer among the endogamous mizo tribe. Breast Cancer Research and Treatment. 209(2):375-387. PMID: 39384723

  59. Piñeros M, Vignat J, Colombet M, Laversanne M, Ferreccio C, Heise K, Mhatre S, Koshiol J, Bray F (2024). Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us? International Journal of Cancer. 156(7):1358-1368. PMID: 39580808.

  60. Puranik AD, Dev ID, Prasad V (2025). Frontiers in radiopharmaceuticals for neuroendocrine tumors. Journal of Neuroendocrinology.

  61. Purohit S, Mandal G, Biswas S, Dalui S, Gupta A, Roy Chowdhury S, Bhattacharyya A (2025). AXL/GAS6 signaling governs differentiation of tumor-associated macrophages in breast cancer. Experimental Cell Research.441 (1): 114324. PMID: 39510154

  62. Raj J, Shah J, Ghanekar S, John G, Goda JS, Chatterjee A (2025). Pharmacological and therapeutic innovation to mitigate Radiation-Induced Cognitive Decline (RICD) in brain tumor Patients. Cancer Letters.

  63. Rajendra A, Sengar M, Korula A, Ganesan P, Jain H, Divya K, Samuel P, Perumal Kalaiyarasi J, Prakash G, John MJ, Palassery R, Nair CK, Shet T, Selvarajan S, Nayak L, Karunakaran P, Fouzia NA, Prakash O, Bagal B, Mehra N, Kumaran S, Epari S, Thorat J, Radhakrishnan V, Abraham A (2025). Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium. Blood Cancer Journal. 15(1):38.

  64. Reddy R, Gaiwak V, Goda JS, Teni T (2025). ‘Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer in-vitro model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis. Biochemistry and Biophysics Reports. 42:101987

  65. Rahman MM, Rahman MS, Islam MR, Gilmour S, Haruyama R, Budukh A, Shankar A, Mishra G,Mehrotra R, Matsuda T, Inoue M, Abe SK (2025). Regional variations and inequalities in testing for early detection of breast and cervical cancer: Evidence from a nationally representative survey in India. Journal of Epidemiology. 35(3):129-140

  66. Sundararajan R, Hegde SR, Panda AK, Christie J, Gadewal N, Venkatraman P. Loss of correlated proteasomal subunit expression selectively promotes the 20SHigh state which underlies luminal breast tumorigenicity. Communications Biology. 8(1): 55.

  67. Sawant V, Mithun S, Jha AK, Rangarajan V (2025). Monte carlo simulation of characteristics of discovery NM/CT 670 pro SPECT system for routinely used diagnostic and therapeutic radionuclides. Journal of Nuclear Medicine Technology.

  68. Saravanan L, Mahale A, Gota V, Khandelia P, Kulkarni OP (2025). Necrostatin-1 attenuates oral squamous cell carcinoma by modulating tumour immune response in mice. Fundamental and Clinical Pharmacology. 39(3):e70008

  69. Saha A, Goswami D, Hole A, Bendale K, Chaudhari P, CM Krishna (2025). Serum Raman spectroscopy explorations in Canine cancers: A pilot study. Journal of Raman Spectroscopy.

  70. Singh AG, Sinha S, Shetty R, Joshi P, Nair SV, Chaturvedi P (2025). Impact of Local Extent of Tumor on the Survival Outcomes for Surgically Treated Tongue Cancers. Head Neck.

  71. Shende R, Dhoble SJ, Gayake U, Saroj D (2025). Monte Carlo modeling and dosimetric validation of GammaMed Plus 192Ir source for HDR brachytherapy application using TOPAS. Applied Radiation and Isotopes. 215:111584. PMID: 39546846

  72. Sharma G, Jadhav P, Banerjee S, Gupta D, Anand M, Ganguly K, Srivastava S, CM Krishna (2025). Serum Raman Spectroscopy – An exploratory study for detection of chronic obstructive pulmonary disease. Vibrational Spectroscopy.

  73. Sharma P, Das D, Khanna D, Budukh A, Khokhar A, Pradhan S, Khanna AK, Chaturvedi P, Badwe R (2025). Prevalence and associated factors of mammography uptake among the women aged 45 years and above: policy implications from the longitudinal ageing study in India wave I survey. BMC Public Health. ;25(1):1073. PMID: 40108533.

  74. Shroff K, Shetty P, Singh V, Epari S, Sahay A, Moiyadi A (2025). Clinical value of optimizing extent of resection in adult diffuse gliomas. Clinical Neurology and Neurosurgery. 251:108838.

  75. Singh M, Katdare A, Ghosh S, Choudhury S, Phurailatpam R, Patil D, Tiwari M, Anaz M, Chougle N, Sable N, Agrawal A, Pawar A, Rangarajan V, Maitre P, Murthy V (2025). PSMA-PET guided Intra- prostatic Boost in Prostate SBRT (PROBE): A phase II trial. International Journal of Radiation Oncology,Biology, Physics.

Category
International
Select Year
2025
order
7
Back to Top